Your browser doesn't support javascript.
loading
Risk of cardiovascular events after an exacerbation of chronic obstructive pulmonary disease: results from the EXACOS-CV cohort study using the PHARMO Data Network in the Netherlands.
Swart, Karin M A; Baak, Brenda N; Lemmens, Louise; Penning-van Beest, Fernie J A; Bengtsson, Camilla; Lobier, Muriel; Hoti, Fabian; Vojinovic, Dina; van Burk, Lindy; Rhodes, Kirsty; Garbe, Edeltraut; Herings, Ron M C; Nordon, Clementine; Simons, Sami O.
Afiliação
  • Swart KMA; PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands. pharmo@pharmo.nl.
  • Baak BN; PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands.
  • Lemmens L; PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands.
  • Penning-van Beest FJA; PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands.
  • Bengtsson C; IQVIA, Real World Solutions, Solna, Sweden.
  • Lobier M; IQVIA, Real World Solutions, Espoo, Finland.
  • Hoti F; IQVIA, Real World Solutions, Espoo, Finland.
  • Vojinovic D; IQVIA, Real World Solutions, Amsterdam, The Netherlands.
  • van Burk L; AstraZeneca, The Hague, The Netherlands.
  • Rhodes K; AstraZeneca, Cambridge, UK.
  • Garbe E; Leibniz Institute for Prevention Research and Epidemiology - BIPS, Bremen, Germany.
  • Herings RMC; PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands.
  • Nordon C; Amsterdam Public Health Research Institute, Amsterdam UMC Location Vrije University Amsterdam, Amsterdam, The Netherlands.
  • Simons SO; AstraZeneca, Cambridge, UK.
Respir Res ; 24(1): 293, 2023 Nov 21.
Article em En | MEDLINE | ID: mdl-37990197

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Doença Pulmonar Obstrutiva Crônica Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Doença Pulmonar Obstrutiva Crônica Idioma: En Ano de publicação: 2023 Tipo de documento: Article